At a time of crisis in his marital life, Gustav Mahler met with Freud. After the meeting with Freud, Mahler's spirits and sexual potency were restored, and his attitude toward his wife changed remarkably. However, these changes were accompanied by an apparent loss of the ability to compose: there is no evidence that Mahler wrote any new music between the summer of 1910, when he saw Freud, and May of 1911, when he died from complications of streptococcal endocarditis. Mahler in effect had chosen human love over artistic creativity. An analysis of the encounter and its effects on the composer's artistic capabilities raises questions about the psychology of genius, adolescent trauma, and psychosomatics.
The author offers a personal selection and discussion of papers that epitomize the enduring relevance of K. R. Eissler's contributions to psychoanalytic therapy. The innovations of technique embodied by these works (on parameters, schizophrenia, adolescence, cure, fees, and the treatment of the dying patient) reveal a therapeutic approach that is a natural extension of psychoanalytic science: patient-centered, maximally comprehensive, and appropriately flexible.
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Jefferson
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.